指南与共识心脑血管急症儿科与产科急症

2021年PACES专家共识声明:儿科患者心血管植入式电子设备的适应证与管理

2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.
指南 / 共识 · Cardiol Young · 2021-08-02
一句话结论PACES发布儿科(≤21岁)心血管植入式电子设备适应证与管理专家共识,推荐按推荐类别和证据水平分级,强调个体化临床判断。

该文件为儿科患者(定义为≤21岁)心血管植入式电子设备(CIEDs)的适应证和管理提供专家共识,重点聚焦特定疾病类别下的CIED适应证。文件同时强调既往成人版与儿科版CIED推荐之间的差异及重要差异的理由,并讨论中低收入国家CIED可及性的障碍及规避策略。推荐代表整个写作委员会的共识意见,按推荐类别和证据水平分级;部分问题不适合临床试验或属罕见病,推荐基于专家共识。文件经PACES成员公开评论及HRS、AHA、ACC、AEPC外部审查,并获APHRS、IHRS、LAHRS认可。

要点

  • 适用人群为≤21岁的儿科患者,文件聚焦特定疾病类别下的CIED适应证与管理。
  • 推荐按推荐类别和证据水平分级,代表整个写作委员会共识意见。
  • 部分问题不适合临床试验或属罕见病,推荐基于专家共识。
  • 文件强调既往成人版与儿科版CIED推荐存在差异并给出理由。
  • 具体推荐不替代临床判断和患者个体化决策。

适用人群与场景

  • 儿科患者,定义为≤21岁。
  • 文件聚焦特定疾病类别下的CIED适应证。

研究设计与关键结果

  • 该文件为专家共识声明,由写作委员会成员根据各自专长分工起草,推荐代表整个写作委员会的共识意见,按推荐类别和证据水平分级。
  • 文件更新并进一步阐明儿科患者CIED的适应证和管理。
  • 文件强调既往成人版与儿科版CIED推荐之间的差异并给出重要差异的理由。
  • 文件讨论中低收入国家CIED可及性的障碍及规避策略。
  • 文件经PACES成员公开评论,并由HRS、AHA、ACC、AEPC科学和临床文件委员会外部审查,获所有合作方及APHRS、IHRS、LAHRS认可。

证据类型、等级与局限

  • 证据类型:专家共识声明。
  • 推荐按推荐类别和证据水平分级。
  • 部分问题不适合临床试验或属罕见病,推荐基于专家共识。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 文件预期为临床医生和患者提供支持,以实现儿科患者适当的CIED使用、适当的管理和适当的随访。
  • 具体推荐不替代临床判断和患者个体化决策的需要。

指南或共识出处

  • 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients(2021年PACES专家共识声明:儿科患者心血管植入式电子设备的适应证与管理),发布机构:Pediatric and Congenital Electrophysiology Society(PACES),年份:2021年。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

In view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories. The document also highlights variations between previously published adult and pediatric CIED recommendations and provides rationale for underlying important differences. The document addresses some of the deterrents to CIED access in low- and middle-income countries and strategies to circumvent them. The document sections were divided up and drafted by the writing committee members according to their expertise. The recommendations represent the consensus opinion of the entire writing committee, graded by class of recommendation and level of evidence. Several questions addressed in this document either do not lend themselves to clinical trials or are rare disease entities, and in these instances recommendations are based on consensus expert opinion. Furthermore, specific recommendations, even when supported by substantial data, do not replace the need for clinical judgment and patient-specific decision-making. The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating committee of the American Heart Association (AHA), the American College of Cardiology (ACC), and the Association for European Paediatric and Congenital Cardiology (AEPC). The document received endorsement by all the collaborators and the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). This document is expected to provide support for clinicians and patients to allow for appropriate CIED use, appropriate CIED management, and appropriate CIED follow-up in pediatric patients.

来源:Cardiol Young,查看原文。版权归原作者所有。

参考来源

  1. Shah MJ, Silka MJ, Silva JNA, et al. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Cardiol Young. 2021. PMID: 34338183. doi:10.1017/S1047951121003413

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。